Tag: (pelareorep)

September 11, 2018

New Collaboration for Oncolytics Biotech and SOLTI

On Monday, Oncolytics Biotech announced the details of a new collaboration for its Phase 3 clinical trial.
September 10, 2018

Oncolytics Biotech Collaborates with SOLTI to Conduct a Window of Opportunity Study in Breast Cancer with Pelareorep

Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC), currently developing REOLYSIN (pelareorep), an intravenously delivered immuno-oncolytic virus turning cold tumors hot, today announced a clinical...